Rajan Sundaram, Thangavel Jayaprakash, Jayaraman Sangumani, Dinesh Ravichandran


CONTEXT: COPD is a progressive disease associated with systemic inflammatory response, which may lead to extra
pulmonary manifestations. This study observed the lipid profile changes in COPD patients and it is correlated with
various parameters.
AIMS AND OBJECTIVES: To study the lipid profile status in stable COPD patients its correlation with other COPD factors.
STUDY DESIGN observational study
MATERIALS AND METHODS The study was conducted on 100 clinically stable COPD patients attended medicine OPD of Government
Rajaji Hospital & Madurai Medical College during the study period from April 2017 to August 2017. 50 matched persons were taken as controls.
Serum lipid profile and spirometry was performed in them.
RESULT: There were 87 Males & 13 Females cases.Total cholesterol (p=0.006) and LDL (p=0.001) was significantly increased and the HDL
was significantly decreased in relation with increasing in COPD stages. (p= 0.02).
CONCLUSION: Periodic monitoring of lipid profile is advised in COPD patients.


COPD, lipid profile, Dyslipidaemia

Full Text:



Alvarez –Sala et al Chronic Obstructive Pulmonary Diseases: Beyond the lungs . (2010). RevistaClinica Espanola, Vol.210, No 3,pp 124-126

Peces-Barba et al(2008) Diagnosis and management of chronic obstructive pulmonary disease: joint guidelines of the Spanish society of pulmonology and Thoracic Surgery (SEPAR) and the Latin American Thoracic Soceity (ALAT). Archivos de bronconeumologia, vol.5,pp. 271-281.

Chatila MC et al ., Comorbidities in Chronic Obstructive Pulmonary Disease AM Thoracsocvol 5. Pp 549-555,2008

cavailles A, Rabin GB, Diximer A et al ., Comorbidities of COPD , EurRespir Rev 2013:22;454-475

Afonso A S M, Verhamme K M C et al, COPD in the general population : Prevalence , incidence and survival , Respiratory Medicine (2011) 105, 1872 -1884

Patel A R C , Hurst JR , Extrapulmonary comorbidities in COPD : State o the art , Respi. Med 5 (5), 647-662 (2011)

)Fessler MB et al , Novel relationship of serum cholesterol with Asthma and wheeze in the united states , J Allergy clin immune.2009 nov ; 124(5):967-74 e 1-15

Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) (2001) Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 285: 2486–2497 )

Textbook , GOODMAN AND GILMAN’S the pharmacological basis of therapeutics 11 th edition , chapter 35

Jindal SK, Aggarwal AN, Chaudhry K, Chhabra SK, D’ Souza GA, Gupta D, et al. A multicentric study on epidemiology of chronic obstructive pulmonary disease and its relationship with tobacco smoking and environmental tobacco smoke exposure. Indian J Chest Dis Allied Sci 2006;48:23‑9.

. McKay AJ, Mahesh PA, Fordham JZ, Majeed A. Prevalence of COPD in India: A systematic review. Prim Care Respir J 2012;21:313‑21

Phillips AM. The influence of environmental factors in chronic bronchitis. J Occup Med 1963; 5: 468–75.

Niranjan MR, Dadapeer K. Lipoprotein Profile in Patients with Chronic Obstructive Pulmonary Disease in a Tertiary Care Hospital in South India. 2011;5(5):990–93.

Rao M V et al Astudy of lipid profile in COPD , JEMDS/Eissn-2278-4802,Pissn-2278-4748/VOL. 4/Issue 42/2015

K Begum, MK Begum, ZH Sarker, MRK Dewan, MJH Siddique. Lipid Profile Status of Chronic Obstructive Pulmonary Disease in Hospitalized Patients. Bangladesh J Med Biochem 2010; 3(2): 42-45 )

Nassaji M et al , plasma lipid level in patients with acute bacterial infections, Turk J Med Sci,2012:42 (3):465-469

Taparia P et al , study on lipid profile in pulmonary tuberculosis patients and relapse cases in relation with disease severity, IJSAR, 2(1), 2015,

Figuesoa V et al , abnormal lipid concentrations in cystic fibrosis AmJ CLIN Nutr 2002;75:1005-11

Savransky V et al , Chronic Chronic intermittent hypoxia induces atherosclerosis, Am J Resp. Crit care med vol 175.pp 1290-1297,2007

Nillawar A N., et al , Evaluation of HS-CRP and Lipid profile in COPD, jcdr ,2013 may, vol-7(5): 801-803

Hosny H, Moussa H et al , Metabolic syndrome and systemic inflammation in patients with COPD, ejcdt (2013) 62,85-89

Fekete T, Mosler R. Plasma lipoproteins in chronic obstructive pulmonary disease. HormMetab Res 1987; 19(12): 661-62.


  • There are currently no refbacks.